Business ❯Pharmaceutical Industry ❯Vaccine Development

Moderna Inc.

FDA Grants Full Approval to Moderna’s Pediatric COVID-19 Vaccine for At-Risk Children

Full licensure of Moderna’s Spikevax for at-risk children underscores federal policy narrowing pediatric COVID-19 vaccination during ongoing legal challenges.

Stories older than 24h

4 ARTICLES

last wk.

Moderna’s mRNA-1010 Flu Vaccine Outperforms Standard Shot and Advances Toward Approval